About this trial
Low temperature plasma radiofofency ablation of tonsil under 70° nasal endoscope can directly view the lesion area on the monitor, clearly enlarge the operating field, and has the advantages of small surgical trauma, good hemostatic effect, light postoperative pain, low probability of postoperative bleeding and quick postoperative recovery of patients, etc. It is a good surgical mode integrating surgery and teaching, and has brought great benefits to patients, and is worth promoting and applying.
Eligibility criteria
Qualifiers
History of recurrent acute attacks of chronic tonsillitis, with the number of attacks >3 times per year for more than 2 years;
accompanied by snoring, choking and apnea during night sleep;
Age 3-65 years old, gender is not limited;
No major systemic diseases, such as cardiovascular and cerebrovascular diseases, liver and kidney insufficiency, hematopoietic system diseases;
Disqualifiers
cardiopulmonary insufficiency;
Patients with systemic blood diseases;
Patients with acute and chronic bronchial or lung infections;
Complicated with severe cardiovascular system disease or hepatic and renal insufficiency;
Trial design
Treatments tested in this trial
- Application and demonstration of endoscope-assisted low-temperature plasma radiofrequency ablation resection of tonsils